We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Top Stock Picks for the Week of January 7th
Lockheed Martin Corporation (LMT - Free Report) , is a global security and aerospace company. Being the largest defense contractor in the world, it enjoys a strong demand for its high-end military equipment in domestic as well as international markets. Consequently, strong order growth has been a primary growth driver for this company. The company has a solid dividend and stock valuation. LMT will be looking to display strength as it nears its next earnings release, which is expected to be February 4, 2019.
Netflix (NFLX - Free Report) ,is the world's leading Internet television network with millions of subscribers in nearly 50 countries who have access to an ever-expanding library of TV shows and movies, including original programming. Netflix shares have outperformed the industry on a year-to-date basis. The company’s expanding subscriber base reflects growing appeal of the streaming platform. Further, the inclusion of Netflix into Sky’s pay TV packages, which it expects to rollout in the fourth quarter, presents significant growth opportunity.
5 Medical Stocks to Buy Now
Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.
New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.
Click here to see the 5 stocks >>